Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple blood test could spot Alzheimer's early

NCT ID NCT07294586

Completed Diagnosis Sponsor: Amoneta Diagnostics SAS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is working on a blood test to help diagnose Alzheimer's disease. Researchers are measuring two specific markers in the blood of 200 people—some with Alzheimer's and some healthy—to see if these markers can reliably tell the difference. The goal is to create a simple, non-invasive diagnostic tool that could lead to earlier detection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test to help diagnose Alzheimer's disease earlier and more accurately.

What could go wrong

This is an early exploratory study, so the biomarkers may not prove reliable enough for a diagnostic test. The results need validation in larger, more diverse groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Alzheimer disease 2 Cognitive Dysfunction dementia disease early-onset autosomal dominant Alzheimer disease Memory Disorders Nerve Degeneration neurodegenerative disease Plaque, Amyloid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE COGNITIVE DECLINE DEMENTIA EARLY-ONSET ALZHEIMER DISEASE LATE ONSET ALZHEIMER DISEASE MEMORY LOSS MILD COGNITIVE IMPAIRMENT (MCI) NEURODEGENERATIVE DISORDERS

Contacts and locations

Locations

  • Hôpitaux Civils de Colmar

    Colmar, Alsace, 68024, France